A phase I study of celecoxib, irinotecan and concurrent radiotherapy in the preoperative treatment of pancreatic cancer

Trial Profile

A phase I study of celecoxib, irinotecan and concurrent radiotherapy in the preoperative treatment of pancreatic cancer

Discontinued
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2010

At a glance

  • Drugs Celecoxib; Irinotecan
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jul 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top